Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Ciprofloxacin × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Febrile Neutropenia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Neutropenia 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Infections 1 Early Stage Breast Cancer 1 Cysts 1 Cystectomy 1 Breast Neoplasms 1

Interventions

Letrozole 18 exemestane 11 Docetaxel 11 Anastrozole 11 Tamoxifen 9 Cyclophosphamide 9 Capecitabine 9 Zoledronic Acid 8 Paclitaxel 8 pegfilgrastim 7 Trastuzumab 7 Fulvestrant 7 Saline Solution 6 liposomal doxorubicin 5 Sodium Chloride 5 Epirubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 palbociclib 4 abemaciclib 4 Tranexamic Acid 4 Filgrastim 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 pegylated granulocyte colony-stimulating factor 3 eribulin 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02173262 2017-11-06

OTT14-03

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡